Frontlight ResearchEarly access
Trial site
Surat Institute of Digestive Sciences
- 4running trials
- 4closed trials
The trials here
What the 8 trials at this site are about, from their registry records.
- Conditions
- Ulcerative colitis5 trials
- Fatty liver disease (MASLD/MASH)3 trials
- Crohn's disease1 trial
- Liver cirrhosis1 trial
- Phase
- Phase 36 trials
- Phase 21 trial
- Phase 41 trial
- Status
- Completed4 trials
- Active, not recruiting2 trials
- Recruiting2 trials
- Lead sponsor
- Abivax S.A.2 trials
- Boehringer Ingelheim2 trials
- Pfizer2 trials
- Alfasigma S.p.A.1 trial
- Takeda1 trial
Running trials
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Fatty liver disease (MASLD/MASH)2 recruiting
- Liver cirrhosis1 recruiting
Closed trials
Completed
ABTECT-2 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -2
Completed
A Study of Vedolizumab in People With Ulcerative Colitis and Crohn's Disease
Completed
Metabolic Interventions to Resolve Non-alcoholic Steatohepatitis (NASH) With Fibrosis (MIRNA)
Completed
Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis
Site data: ClinicalTrials.govUpdated 12 Nov 2026